Downregulation of Dickkopf-3 disrupts prostate acinar morphogenesis through TGF-β/smad signalling

Journal of Cell Science

Volumn 126, Issue 8, 2013, Pages 1858-1867

  Romero, Diana ^a   Kawano, Yoshiaki ^a,f   Bengoa, Nora ^b   Walker, Marjorie M ^c,g   Maltry, Nicole ^d   Niehrs, Christof ^d,e   Waxman, Jonathan ^a   Kypta, Robert ^a,b  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

^b CIC BIOGUNE   (Spain)

^c ST MARY S HOSPITAL   (United Kingdom)

^d GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^e INSTITUTE OF MOLECULAR BIOLOGY   (Armenia)

^f KUMAMOTO UNIVERSITY   (Japan)

^g UNIVERSITY OF NEWCASTLE   (Australia)

Author keywords

Acinar morphogenesis; Dkk 3; Prostate; TGF

Indexed keywords

DICKKOPF 3 PROTEIN; SMAD PROTEIN; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG; WNT PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL CULTURE; CELL PROLIFERATION; CONTROLLED STUDY; DOWN REGULATION; EPITHELIUM CELL; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; MORPHOGENESIS; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROSTATE; PROSTATE EPITHELIUM; SIGNAL TRANSDUCTION;

ACINAR MORPHOGENESIS; DKK-3; PROSTATE; TGF-Β;

ANIMALS; BLOTTING, WESTERN; CELL LINE; HUMANS; IMMUNOHISTOCHEMISTRY; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; MALE; MICE; MICE, KNOCKOUT; MORPHOGENESIS; PROSTATE; SMAD PROTEINS; TRANSFORMING GROWTH FACTOR BETA;

EID: 84877946647     PISSN: 00219533     EISSN: 14779137     Source Type: Journal    
DOI: 10.1242/jcs.119388     Document Type: Article

References (67)

1. Abarzua, F., Sakaguchi, M., Takaishi, M., Nasu, Y., Kurose, K., Ebara, S., Miyazaki, M., Namba, M., Kumon, H. and Huh, N. H. (2005). Adenovirusmediated overexpression of REIC/Dkk-3 selectively induces apoptosis in human prostate cancer cells through activation of c-Jun-NH2-kinase. Cancer Res. 65, 9617-9622.
2. Akhmetshina, A., Palumbo, K., Dees, C., Bergmann, C., Venalis, P., Zerr, P., Horn, A., Kireva, T., Beyer, C., Zwerina, J. et al. (2012). Activation of canonical Wnt signalling is required for TGF-β-mediated fibrosis. Nat. Commun. 3, 735.
3. Ao, M., Williams, K., Bhowmick, N. A. and Hayward, S. W. (2006). Transforming growth factor-beta promotes invasion in tumorigenic but not in nontumorigenic human prostatic epithelial cells. Cancer Res. 66, 8007-8016.
4. Bello, D., Webber, M. M., Kleinman, H. K., Wartinger, D. D. and Rhim, J. S. (1997). Androgen responsive adult human prostatic epithelial cell lines immortalized by human papillomavirus 18. Carcinogenesis 18, 1215-1223.
5. Bello-DeOcampo, D., Kleinman, H. K., Deocampo, N. D. and Webber, M. M. (2001a). Laminin-1 and alpha6beta1 integrin regulate acinar morphogenesis of normal and malignant human prostate epithelial cells. Prostate 46, 142-153.
6. Bello-DeOcampo, D., Kleinman, H. K. and Webber, M. M. (2001b). The role of alpha 6 beta 1 integrin and EGF in normal and malignant acinar morphogenesis of human prostatic epithelial cells. Mutat. Res. 480-481, 209-217.
7. Bhatia-Gaur, R., Donjacour, A. A., Sciavolino, P. J., Kim, M., Desai, N., Young, P., Norton, C. R., Gridley, T., Cardiff, R. D., Cunha, G. R. et al. (1999). Roles for Nkx3.1 in prostate development and cancer. Genes Dev. 13, 966-977.
8. Bierie, B. and Moses, H. L. (2006). Tumour microenvironment: TGFbeta: the molecular Jekyll and Hyde of cancer. Nat. Rev. Cancer 6, 506-520.
9. Bookout, A. L. and Mangelsdorf, D. J. (2003). Quantitative real-time PCR protocol for analysis of nuclear receptor signaling pathways. Nucl. Recept. Signal. 1, e012.
10. Chen, B., Dodge, M. E., Tang, W., Lu, J., Ma, Z., Fan, C. W., Wei, S., Hao, W., Kilgore, J., Williams, N. S. et al. (2009a). Small molecule-mediated disruption of Wnt-dependent signaling in tissue regeneration and cancer. Nat. Chem. Biol. 5, 100-107.
11. Chen, J., Watanabe, M., Huang, P., Sakaguchi, M., Ochiai, K., Nasu, Y., Ouchida, M., Huh, N. H., Shimizu, K., Kashiwakura, Y. et al. (2009b). REIC/Dkk-3 stable transfection reduces the malignant phenotype of mouse prostate cancer RM9 cells. Int. J. Mol. Med. 24, 789-794.
12. Clevers, H. (2006). Wnt/beta-catenin signaling in development and disease. Cell 127, 469-480.
13. Debnath, J., Mills, K. R., Collins, N. L., Reginato, M. J., Muthuswamy, S. K. and Brugge, J. S. (2002). The role of apoptosis in creating and maintaining luminal space within normal and oncogene-expressing mammary acini. Cell 111, 29-40.
14. Debnath, J., Muthuswamy, S. K. and Brugge, J. S. (2003). Morphogenesis and oncogenesis of MCF-10A mammary epithelial acini grown in three-dimensional basement membrane cultures. Methods 30, 256-268.
15. del Barco Barrantes, I., Montero-Pedrazuela, A., Guadaño-Ferraz, A., Obregon, M. J., Martinez de Mena, R., Gailus-Durner, V., Fuchs, H., Franz, T. J., Kalaydjiev, S., Klempt, M. et al. (2006). Generation and characterization of dickkopf3 mutant mice. Mol. Cell. Biol. 26, 2317-2326.
16. Dennler, S., Itoh, S., Vivien, D., ten Dijke, P., Huet, S. and Gauthier, J. M. (1998). Direct binding of Smad3 and Smad4 to critical TGF beta-inducible elements in the promoter of human plasminogen activator inhibitor-type 1 gene. EMBO J. 17, 3091-3100.
17. Edamura, K., Nasu, Y., Takaishi, M., Kobayashi, T., Abarzua, F., Sakaguchi, M., Kashiwakura, Y., Ebara, S., Saika, T., Watanabe, M. et al. (2007). Adenovirusmediated REIC/Dkk-3 gene transfer inhibits tumor growth and metastasis in an orthotopic prostate cancer model. Cancer Gene Ther. 14, 765-772.
18. Francis, J. C., McCarthy, A., Thomsen, M. K., Ashworth, A. and Swain, A. (2010). Brca2 and Trp53 deficiency cooperate in the progression of mouse prostate tumourigenesis. PLoS Genet. 6, e1000995.
19. Giannini, A. L., Vivanco, M. and Kypta, R. M. (2000). alpha-catenin inhibits betacatenin signaling by preventing formation of a beta-catenin T-cell factor*DNA complex. J. Biol. Chem. 275, 21883-21888.
20. Glinka, A., Wu, W., Delius, H., Monaghan, A. P., Blumenstock, C. and Niehrs, C. (1998). Dickkopf-1 is a member of a new family of secreted proteins and functions in head induction. Nature 391, 357-362.
21. Gu, Y. M., Ma, Y. H., Zhao, W. G. and Chen, J. (2011). Dickkopf3 overexpression inhibits pancreatic cancer cell growth in vitro. World J. Gastroenterol. 17, 3810-3817.
22. Guo, H. B., Johnson, H., Randolph, M., Nagy, T., Blalock, R. and Pierce, M. (2010). Specific posttranslational modification regulates early events in mammary carcinoma formation. Proc. Natl. Acad. Sci. USA 107, 21116-21121.
23. Härmä, V., Virtanen, J., Mäkelä, R., Happonen, A., Mpindi, J. P., Knuuttila, M., Kohonen, P., Lötjönen, J., Kallioniemi, O. and Nees, M. (2010). A comprehensive panel of three-dimensional models for studies of prostate cancer growth, invasion and drug responses. PLoS ONE 5, e10431.
24. Hoang, B. H., Kubo, T., Healey, J. H., Yang, R., Nathan, S. S., Kolb, E. A., Mazza, B., Meyers, P. A. and Gorlick, R. (2004). Dickkopf 3 inhibits invasion and motility of Saos-2 osteosarcoma cells by modulating the Wnt-beta-catenin pathway. Cancer Res. 64, 2734-2739.
25. Hsu, R. J., Lin, C. C., Su, Y. F. and Tsai, H. J. (2011). dickkopf-3-related gene regulates the expression of zebrafish myf5 gene through phosphorylated p38adependent Smad4 activity. J. Biol. Chem. 286, 6855-6864.
26. Inman, G. J. (2011). Switching TGFb from a tumor suppressor to a tumor promoter. Curr. Opin. Genet. Dev. 21, 93-99.
27. Jinnin, M., Ihn, H. and Tamaki, K. (2006). Characterization of SIS3, a novel specific inhibitor of Smad3, and its effect on transforming growth factor-beta1-induced extracellular matrix expression. Mol. Pharmacol. 69, 597-607.
28. Jones, E., Pu, H. and Kyprianou, N. (2009). Targeting TGF-beta in prostate cancer: therapeutic possibilities during tumor progression. Expert Opin. Ther. Targets 13, 227-234.
29. Kane, N., Jones, M., Brosens, J. J., Saunders, P. T., Kelly, R. W. and Critchley, H. O. (2008). Transforming growth factor-beta1 attenuates expression of both the progesterone receptor and Dickkopf in differentiated human endometrial stromal cells. Mol. Endocrinol. 22, 716-728.
30. Kashiwakura, Y., Ochiai, K., Watanabe, M., Abarzua, F., Sakaguchi, M., Takaoka, M., Tanimoto, R., Nasu, Y., Huh, N. H. and Kumon, H. (2008). Down-regulation of inhibition of differentiation-1 via activation of activating transcription factor 3 and Smad regulates REIC/Dickkopf-3-induced apoptosis. Cancer Res. 68, 8333-8341.
31. Kawano, Y., Kitaoka, M., Hamada, Y., Walker, M. M., Waxman, J. and Kypta, R. M. (2006). Regulation of prostate cell growth and morphogenesis by Dickkopf-3. Oncogene 25, 6528-6537.
32. Kawano, Y., Diez, S., Uysal-Onganer, P., Darrington, R. S., Waxman, J. and Kypta, R. M. (2009). Secreted Frizzled-related protein-1 is a negative regulator of androgen receptor activity in prostate cancer. Br. J. Cancer 100, 1165-1174.
33. Krupnik, V. E., Sharp, J. D., Jiang, C., Robison, K., Chickering, T. W., Amaravadi, L., Brown, D. E., Guyot, D., Mays, G., Leiby, K. et al. (1999). Functional and structural diversity of the human Dickkopf gene family. Gene 238, 301-313.
34. Kypta, R. M. and Waxman, J. (2012). Wnt/beta-catenin signaling in prostate cancer. Nat. Rev. Urol. 9, 418-428.
35. Lee, G. Y., Kenny, P. A., Lee, E. H. and Bissell, M. J. (2007). Three-dimensional culture models of normal and malignant breast epithelial cells. Nat. Methods 4, 359-365.
36. Lee, E. J., Jo, M., Rho, S. B., Park, K., Yoo, Y. N., Park, J., Chae, M., Zhang, W. and Lee, J. H. (2009). Dkk3, downregulated in cervical cancer, functions as a negative regulator of beta-catenin. Int. J. Cancer 124, 287-297.
37. Liu, R., Zhou, Z., Huang, J. and Chen, C. (2011). PMEPA1 promotes androgen receptor-negative prostate cell proliferation through suppressing the Smad3/4-c-Mycp21 Cip1 signaling pathway. J. Pathol. 223, 683-694.
38. Lodygin, D., Epanchintsev, A., Menssen, A., Diebold, J. and Hermeking, H. (2005). Functional epigenomics identifies genes frequently silenced in prostate cancer. Cancer Res. 65, 4218-4227.
39. Mao, B. and Niehrs, C. (2003). Kremen2 modulates Dickkopf2 activity during Wnt/ LRP6 signaling. Gene 302, 179-183.
40. Mao, B., Wu, W., Li, Y., Hoppe, D., Stannek, P., Glinka, A. and Niehrs, C. (2001). LDL-receptor-related protein 6 is a receptor for Dickkopf proteins. Nature 411, 321-325.
41. Massagué, J. (2008). TGFbeta in Cancer. Cell 134, 215-230.
42. Matsuyama, S., Iwadate, M., Kondo, M., Saitoh, M., Hanyu, A., Shimizu, K., Aburatani, H., Mishima, H. K., Imamura, T., Miyazono, K. et al. (2003). SB-431542 and Gleevec inhibit transforming growth factor-beta-induced proliferation of human osteosarcoma cells. Cancer Res. 63, 7791-7798.
43. Mazor, M., Kawano, Y., Zhu, H., Waxman, J. and Kypta, R. M. (2004). Inhibition of glycogen synthase kinase-3 represses androgen receptor activity and prostate cancer cell growth. Oncogene 23, 7882-7892.
44. Nakamura, R. E. and Hackam, A. S. (2010). Analysis of Dickkopf3 interactions with Wnt signaling receptors. Growth Factors 28, 232-242.
45. Niehrs, C. (2006). Function and biological roles of the Dickkopf family of Wnt modulators. Oncogene 25, 7469-7481.
46. Ochiai, K., Watanabe, M., Ueki, H., Huang, P., Fujii, Y., Nasu, Y., Noguchi, H., Hirata, T., Sakaguchi, M., Huh, N. H. et al. (2011). Tumor suppressor REIC/Dkk-3 interacts with the dynein light chain, Tctex-1. Biochem. Biophys. Res. Commun. 412, 391-395.
47. Onai, T., Takai, A., Setiamarga, D. H. and Holland, L. Z. (2012). Essential role of Dkk3 for head formation by inhibiting Wnt/β-catenin and Nodal/Vg1 signaling pathways in the basal chordate amphioxus. Evol. Dev. 14, 338-350.
48. Papatriantafyllou, M., Moldenhauer, G., Ludwig, J., Tafuri, A., Garbi, N., Hollmann, G., Küblbeck, G., Klevenz, A., Schmitt, S., Pougialis, G. et al. (2012). Dickkopf-3, an immune modulator in peripheral CD8 T-cell tolerance. Proc. Natl. Acad. Sci. USA 109, 1631-1636.
49. Pinho, S. and Niehrs, C. (2007). Dkk3 is required for TGF-beta signaling during Xenopus mesoderm induction. Differentiation 75, 957-967.
50. Salm, S. N., Burger, P. E., Coetzee, S., Goto, K., Moscatelli, D. and Wilson, E. L. (2005). TGF-beta maintains dormancy of prostatic stem cells in the proximal region of ducts. J. Cell Biol. 170, 81-90.
51. Shappell, S. B., Thomas, G. V., Roberts, R. L., Herbert, R., Ittmann, M. M., Rubin, M. A., Humphrey, P. A., Sundberg, J. P., Rozengurt, N., Barrios, R. et al. (2004). Prostate pathology of genetically engineered mice: definitions and classification. The consensus report from the Bar Harbor meeting of the Mouse Models of Human Cancer Consortium Prostate Pathology Committee. Cancer Res. 64, 2270-2305.
52. Singha, P. K., Yeh, I. T., Venkatachalam, M. A. and Saikumar, P. (2010). Transforming growth factor-beta (TGF-beta)-inducible gene TMEPAI converts TGFbeta from a tumor suppressor to a tumor promoter in breast cancer. Cancer Res. 70, 6377-6383.
53. Sugimura, Y., Cunha, G. R. and Donjacour, A. A. (1986). Morphogenesis of ductal networks in the mouse prostate. Biol. Reprod. 34, 961-971.
54. Tobin, S. W., Douville, K., Benbow, U., Brinckerhoff, C. E., Memoli, V. A. and Arrick, B. A. (2002). Consequences of altered TGF-beta expression and responsiveness in breast cancer: evidence for autocrine and paracrine effects. Oncogene 21, 108-118.
55. Tokar, E. J., Ancrile, B. B., Cunha, G. R. and Webber, M. M. (2005). Stem/ progenitor and intermediate cell types and the origin of human prostate cancer. Differentiation 73, 463-473.
56. Tsuji, T., Miyazaki, M., Sakaguchi, M., Inoue, Y. and Namba, M. (2000). A REIC gene shows down-regulation in human immortalized cells and human tumor-derived cell lines. Biochem. Biophys. Res. Commun. 268, 20-24.
57. Tudzarova, S., Trotter, M. W., Wollenschlaeger, A., Mulvey, C., Godovac-Zimmermann, J., Williams, G. H. and Stoeber, K. (2010). Molecular architecture of the DNA replication origin activation checkpoint. EMBO J. 29, 3381-3394.
58. Tyson, D. R., Inokuchi, J., Tsunoda, T., Lau, A. and Ornstein, D. K. (2007). Culture requirements of prostatic epithelial cell lines for acinar morphogenesis and lumen formation in vitro: role of extracellular calcium. Prostate 67, 1601-1613.
59. Ueno, K., Hirata, H., Majid, S., Chen, Y., Zaman, M. S., Tabatabai, Z. L., Hinoda, Y. and Dahiya, R. (2011). Wnt antagonist DICKKOPF-3 (Dkk-3) induces apoptosis in human renal cell carcinoma. Mol. Carcinog. 50, 449-457.
60. Uysal-Onganer, P., Kawano, Y., Caro, M., Walker, M. M., Diez, S., Darrington, R. S., Waxman, J. and Kypta, R. M. (2010). Wnt-11 promotes neuroendocrine-like differentiation, survival and migration of prostate cancer cells. Mol. Cancer 9, 55.
61. Veeck, J. and Dahl, E. (2012). Targeting the Wnt pathway in cancer: the emerging role of Dickkopf-3. Biochim. Biophys. Acta 1825, 18-28.
62. Veeman, M. T., Slusarski, D. C., Kaykas, A., Louie, S. H. and Moon, R. T. (2003). Zebrafish prickle, a modulator of noncanonical Wnt/Fz signaling, regulates gastrulation movements. Curr. Biol. 13, 680-685.
63. Webber, M. M., Bello, D., Kleinman, H. K. and Hoffman, M. P. (1997). Acinar differentiation by non-malignant immortalized human prostatic epithelial cells and its loss by malignant cells. Carcinogenesis 18, 1225-1231.
64. Webber, M. M., Quader, S. T., Kleinman, H. K., Bello-DeOcampo, D., Storto, P. D., Bice, G., DeMendonca-Calaca, W. and Williams, D. E. (2001). Human cell lines as an in vitro/in vivo model for prostate carcinogenesis and progression. Prostate 47, 1-13.
65. Yue, W., Sun, Q., Dacic, S., Landreneau, R. J., Siegfried, J. M., Yu, J. and Zhang, L. (2008). Downregulation of Dkk3 activates beta-catenin/TCF-4 signaling in lung cancer. Carcinogenesis 29, 84-92.
66. Zenzmaier, C., Untergasser, G., Hermann, M., Dirnhofer, S., Sampson, N. and Berger, P. (2008). Dysregulation of Dkk-3 expression in benign and malignant prostatic tissue. Prostate 68, 540-547.
67. Zhang, Q., Helfand, B. T., Jang, T. L., Zhu, L. J., Chen, L., Yang, X. J., Kozlowski, J., Smith, N., Kundu, S. D., Yang, G. et al. (2009). Nuclear factor-kappaB-mediated transforming growth factor-beta-induced expression of vimentin is an independent predictor of biochemical recurrence after radical prostatectomy. Clin. Cancer Res. 15, 3557-3567.